<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://prforpharma.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/2.9.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.2" -->
<!-- generated-on="03/10/2010 6:13 pm" -->
<!-- Debug: Total comment count: 151 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://prforpharma.com/</loc>
		<lastmod>2010-03-10T18:12:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
<!-- Debug: Priority report of postID 179: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/10/what-social-media-tools-are-you-overlooking/</loc>
		<lastmod>2010-03-10T18:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 177: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/09/phrma-puts-pressure-on-fda-to-issue-social-media-guidance/</loc>
		<lastmod>2010-03-09T20:08:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/05/pharmaceutical-social-media-in-phases-and-on-a-budget/</loc>
		<lastmod>2010-03-05T21:31:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/03/04/hoarding-knowledge-does-not-equate-to-power/</loc>
		<lastmod>2010-03-04T15:53:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/25/crafting-the-message-for-internal-pharma-social-media-audiences/</loc>
		<lastmod>2010-02-25T22:09:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 166: Comments: 3 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/22/evaluating-pharmaceutical-twitter-accounts/</loc>
		<lastmod>2010-02-22T21:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 158: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/19/structuring-your-internal-social-media-team/</loc>
		<lastmod>2010-02-19T17:45:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 156: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/18/the-importance-of-seo-and-social-media-working-together/</loc>
		<lastmod>2010-02-18T21:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 154: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/17/pharma-social-media-needs-to-embrace-middle-ground/</loc>
		<lastmod>2010-02-17T21:04:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/chris-iafolla/</loc>
		<lastmod>2010-02-15T14:57:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/pharmaceutical-social-media-resources/</loc>
		<lastmod>2010-02-15T14:41:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/12/roi-for-pharma-social-media-the-case-for-change/</loc>
		<lastmod>2010-02-12T20:43:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 141: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/11/can-pharma-marketing-hope-to-create-brand-advocates/</loc>
		<lastmod>2010-02-11T19:05:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 138: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/10/impact-of-google-and-bing-health-on-pharma-social-media/</loc>
		<lastmod>2010-02-10T20:10:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/</loc>
		<lastmod>2010-02-04T21:29:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/02/pharma-social-media-is-ad-hoc-at-expense-of-strategy/</loc>
		<lastmod>2010-02-03T13:44:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 3 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/02/01/analyzing-pharma-social-media-working-group%e2%80%99s-response/</loc>
		<lastmod>2010-02-01T19:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 125: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/29/defining-value-in-pharma-social-media/</loc>
		<lastmod>2010-01-31T15:27:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/25/comparing-social-media-to-pharma-sales-reps/</loc>
		<lastmod>2010-01-25T21:45:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 112: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/14/don%e2%80%99t-write-off-traditional-pr-entirely-for-social-media/</loc>
		<lastmod>2010-01-22T03:08:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 118: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/21/why-do-pharma-companies-fire-their-social-media-agency/</loc>
		<lastmod>2010-01-22T03:07:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 116: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/20/social-media-pharmas-sandbox/</loc>
		<lastmod>2010-01-20T20:21:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/want-to-get-a-hold-of-me/</loc>
		<lastmod>2010-01-15T21:46:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 110: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/12/pharma-social-media-echo-chamber/</loc>
		<lastmod>2010-01-12T21:24:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 108: Comments: 3 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/07/pharma-social-media-there-is-no-easy-road/</loc>
		<lastmod>2010-01-07T17:03:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 104: Comments: 6 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2010/01/05/does-shouting-amount-to-pharmaceutical-social-media/</loc>
		<lastmod>2010-01-06T15:01:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 102: Comments: 7 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/22/two-sentences-to-define-pharma-social-media/</loc>
		<lastmod>2009-12-22T19:47:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 99: Comments: 4 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/21/listen-closely-for-the-voice-of-the-patient/</loc>
		<lastmod>2009-12-21T22:19:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 96: Comments: 11 of 151 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/18/pharma-social-media-sea-change-or-fad/</loc>
		<lastmod>2009-12-18T20:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 94: Comments: 10 of 151 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/15/the-pharma-social-media-land-grab/</loc>
		<lastmod>2009-12-15T20:55:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 91: Comments: 13 of 151 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/10/educating-legal-and-regulatory-departments-inside-pharmaceutical-companies-on-social-media/</loc>
		<lastmod>2009-12-13T13:23:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 88: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/09/pharma-social-media-brings-discomfort-in-lack-of-knowledge/</loc>
		<lastmod>2009-12-09T21:00:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 81: Comments: 31 of 151 = 0.2 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/03/do-patients-want-pharma-in-social-media/</loc>
		<lastmod>2009-12-04T15:52:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 85: Comments: 10 of 151 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/04/my-advice-for-pharma-social-media-programs-ignore-the-consumer/</loc>
		<lastmod>2009-12-04T14:55:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 79: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/12/01/does-pharma-need-social-media-purists-or-realists/</loc>
		<lastmod>2009-12-01T22:11:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 77: Comments: 5 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/24/genzyme-vial-contamination-offers-insight-into-pharma-crisis-communications/</loc>
		<lastmod>2009-11-24T19:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 75: Comments: 9 of 151 = 0.1 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/20/why-pharma-needs-social-media/</loc>
		<lastmod>2009-11-20T18:06:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 70: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/18/forget-about-stealth-mode-pr-brings-biotechs-higher-valuations/</loc>
		<lastmod>2009-11-18T20:59:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 68: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/16/why-guidance-will-not-be-the-most-important-thing-to-come-out-of-the-fda-social-media-hearings/</loc>
		<lastmod>2009-11-16T21:45:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 63: Comments: 7 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/13/pharmaceutical-social-media-focus-on-the-patient-and-return-on-health/</loc>
		<lastmod>2009-11-13T17:02:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 61: Comments: 3 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/11/fda-public-hearing-on-social-media-what-will-it-bring/</loc>
		<lastmod>2009-11-11T20:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 59: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/10/the-implications-of-an-fda-approved-symbol-for-branded-social-media/</loc>
		<lastmod>2009-11-10T16:15:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 57: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/06/going-the-safe-route-in-social-media/</loc>
		<lastmod>2009-11-06T16:30:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 54: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/11/03/regulatory-requirements-a-convenient-excuse-for-pharma-to-avoid-social-media/</loc>
		<lastmod>2009-11-03T23:07:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 52: Comments: 2 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/28/will-the-fda-hearing-have-any-impact-on-pharma-social-media/</loc>
		<lastmod>2009-10-28T20:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 50: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/26/change-the-script-for-pharma-social-media/</loc>
		<lastmod>2009-10-26T20:00:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 47: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/22/pharma%e2%80%99s-shift-to-corporate-branding/</loc>
		<lastmod>2009-10-22T20:14:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/20/deflecting-myopia-is-pharma-marketing-stuck-in-neutral/</loc>
		<lastmod>2009-10-20T21:10:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 43: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/16/should-pharma-companies-institute-a-no-posting-on-google-sidewiki-policy/</loc>
		<lastmod>2009-10-16T17:56:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 37: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/15/google-sidewiki-forcing-the-social-media-hand-of-pharma/</loc>
		<lastmod>2009-10-16T13:23:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 35: Comments: 1 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/15/welcome-to-prforpharma-com/</loc>
		<lastmod>2009-10-15T16:03:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 31: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/less-trinkets-more-pr-in-pharma/</loc>
		<lastmod>2009-10-13T17:37:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 29: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/is-a-press-release-job-safety-for-pharma-pr-managers/</loc>
		<lastmod>2009-10-13T16:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 26: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/pr-in-the-pharma-world/</loc>
		<lastmod>2009-10-13T16:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/social-media-lock-down-in-pharma/</loc>
		<lastmod>2009-10-13T15:45:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 0 of 151 = 0 points -->
	<url>
		<loc>http://prforpharma.com/2009/10/13/%e2%80%9cpay-for-performance%e2%80%9d-in-pharma-cutting-out-the-middle-man/</loc>
		<lastmod>2009-10-13T15:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://prforpharma.com/about/</loc>
		<lastmod>2009-10-09T22:40:26+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>